Zomedica (ZOMDF) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Zomedica Corp   (NONE: ZOMDF)


Zomedica 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Zomedica 's ROA in the third quarter of 2026?
Zomedica Corp recorded a cumulative net loss of $-16 million during 12 months ending in the third quarter of 2026, resulting in a negative return on assets (ROA) of -13.3%.

However, within the Healthcare sector 331 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 3422, from total ROA ranking in the second quarter of 2026 at 4738.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Total Assets Change -11.39 % -13.43 % -13.95 % -38.74 % -39.67 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -16 -19 -23 -82 -85
Return On Assets (TTM) -13.3 % -15.29 % -17.57 % -61.33 % -55.04 %
ZOMDF's Total Ranking # 3422 # 4738 # 4101 # 4089 # 4203
Total Assets (TTM) in million 114 118 122 127 129
Seq. Total Assets Change -3.12 % -2.79 % -4.33 % -1.65 % -5.35 %
Seq. Net Income Change - - - - -

ZOMDF's 5 Years Annual ROA >> Back to ZOMDF Management Effectiveness >> Compare ZOMDF ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 117
Sector # 332
Overall # 3334

Return On Assets Statistics
High Average Low
464.2 %
58.37 %
-60.93 %
(Mar 31 2019)   (Dec 31 2025)





Financial Statements
Zomedica 's Assets $ 114 million ZOMDF's Balance sheet
Zomedica 's Income $ -3 million Quarterly ZOMDF's Income Statement
ZOMDF's Income by Division See ZOMDF's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2020)
FY 2020
Y / Y Total Assets Change -38.74 % -18.1 % -9.45 % 322.73 % 1481.27 %
Total Assets in million 127 207 253 280 66
Y / Y Net Income Change - - - - -14.52 %
Net Income in million -82 -47 -35 -17 17
Annual Return On Assets -64.44 % -22.66 % -13.64 % -6.09 % 25.57 %

ZOMDF's 5 Years Annual ROA >> Back to ZOMDF Management Effectiveness >> Compare ZOMDF ROA to its Competitors



More Return On Assets Ratios
ZOMDF's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ZOMDF's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ZOMDF's Competitors
Subscribers only: Roa for Zomedica 's Suppliers
Subscribers only: Return On Assets for ZOMDF's Customers

You may also want to know
ZOMDF's Roi ZOMDF's Inventory Turnover Ratio ZOMDF's Growth Rates ZOMDF's Dividend Comparisons
ZOMDF's Profitability Ratios ZOMDF's Asset Turnover Ratio ZOMDF's Dividend Growth
ZOMDF's Roe ZOMDF's Valuation Ratios ZOMDF's Financial Strength Ratios ZOMDF's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA

Date modified: 2026-11-07T13:23:09+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.